Citadel Advisors Portfolio holdings
Citadel Advisors, founded in 1990 by Kenneth C. Griffin as Citadel LLC and headquartered in Chicago, Illinois, is one of the world’s most prominent hedge funds, managing tens of billions in assets through sophisticated quantitative trading strategies. The firm excels in market-making and high-frequency trading across asset classes like equities, fixed income, options, and commodities, leveraging cutting-edge technology and data analysis to generate returns. Citadel operates two main arms: its hedge fund business, which serves institutional and high-net-worth investors, and Citadel Securities, a leading market maker that facilitates a significant portion of U.S. equity and options trades. Known for its secretive, high-performance culture, Citadel has grown into a financial titan under Griffin’s leadership, influencing global markets with its scale and innovation.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Boeing
BA
|
+$830M |
| 2 |
UnitedHealth
UNH
|
+$769M |
| 3 |
Arthur J. Gallagher & Co
AJG
|
+$691M |
| 4 |
Amazon
AMZN
|
+$654M |
| 5 |
Bank of America
BAC
|
+$634M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.23B |
| 2 |
NVIDIA
NVDA
|
+$550M |
| 3 |
Spotify
SPOT
|
+$473M |
| 4 |
Citigroup
C
|
+$460M |
| 5 |
Boston Scientific
BSX
|
+$428M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 82.83% |
| 2 | Healthcare | 3.13% |
| 3 | Technology | 2.97% |
| 4 | Financials | 2.19% |
| 5 | Consumer Discretionary | 2.09% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
13251
PUT
Zevia
ZVIA
$87.3M
| $16.8K | ﹤0.01% |
4,000
+1,100
| +38% | +$2.24K |
2024 Q1
3 quarters
|
|
13252
PUT
ProQR Therapeutics
PRQR
$236M
| $16.7K | ﹤0.01% |
6,300
+600
| +11% | +$1.91K |
2023 Q4
4 quarters
|
|
|
KAPA
13253
Kairos Pharma
KAPA
$5.25M
| $16.7K | ﹤0.01% |
+1,567
| New | +$16.8K |
2024 Q4
0 quarters
|
|
13254
PUT
GSI Technology
GSIT
$217M
| $16.7K | ﹤0.01% |
5,500
-1,900
| -26% | -$5.98K |
2024 Q3
1 quarter
|
|
|
SSY
13255
DELISTED
SunLink Health Systems
SSY
| $16.6K | ﹤0.01% |
+18,919
| New | +$15.7K |
2024 Q4
0 quarters
|
|
13256
CALL
Matthews International
MATW
$603M
| $16.6K | ﹤0.01% |
600
-1,100
| -65% | -$28.2K |
2022 Q4
8 quarters
|
|
13257
PUT
State Street SPDR S&P Aerospace & Defense ETF
XAR
$5.53B
| $16.6K | ﹤0.01% |
100
-1,200
| -92% | -$198K |
2024 Q3
1 quarter
|
|
13258
CALL
BCB Bancorp
BCBP
$260M
| $16.6K | ﹤0.01% |
1,400
-4,600
| -77% | -$57.7K |
2023 Q4
4 quarters
|
|
13259
CALL
Bionano Genomics
BNGO
$17.1M
| $16.5K | ﹤0.01% |
956
+178
| +23% | +$3.04K |
2021 Q1
15 quarters
|
|
13260
Primech Holdings
PMEC
$22.7M
| $16.5K | ﹤0.01% |
+24,666
| New | +$18.3K |
2024 Q4
0 quarters
|
|
13261
Acumen Pharmaceuticals
ABOS
$154M
| $16.5K | ﹤0.01% |
9,597
-7,315
| -43% | -$17.6K |
2023 Q1
7 quarters
|
|
13262
PUT
VanEck Oil Refiners ETF
CRAK
$680M
| $16.5K | ﹤0.01% |
+600
| New | +$18.8K |
2024 Q4
0 quarters
|
|
13263
CALL
Direxion Daily Industrials Bull 3X ETF
DUSL
$43M
| $16.5K | ﹤0.01% |
300
-200
| -40% | -$13.3K |
2024 Q3
1 quarter
|
|
13264
PUT
Safety Insurance
SAFT
$1.53B
| $16.5K | ﹤0.01% |
200
| – | – |
2022 Q4
8 quarters
|
|
13265
CALL
Anixa Biosciences
ANIX
$103M
| $16.5K | ﹤0.01% |
7,100
-13,900
| -66% | -$43.2K |
2024 Q3
1 quarter
|
|
13266
Dominari Holdings
DOMH
$50.9M
| $16.5K | ﹤0.01% |
+16,518
| New | +$27.1K |
2024 Q4
0 quarters
|
|
13267
Outlook Therapeutics
OTLK
$145M
| $16.4K | ﹤0.01% |
+8,692
| New | +$35.8K |
2024 Q4
0 quarters
|
|
13268
PUT
Mitsubishi UFJ Financial
MUFG
$259B
| $16.4K | ﹤0.01% |
1,400
-3,200
| -70% | -$36K |
2023 Q2
6 quarters
|
|
13269
QuickLogic
QUIK
$213M
| $16.4K | ﹤0.01% |
1,447
-57,780
| -98% | -$469K |
2022 Q4
8 quarters
|
|
|
NAK
13270
CALL
Northern Dynasty Minerals
NAK
$731M
| $16.3K | ﹤0.01% |
28,100
-10,000
| -26% | -$4.46K |
2017 Q1
31 quarters
|
|
|
TSE
13271
CALL
DELISTED
Trinseo
TSE
| $16.3K | ﹤0.01% |
3,200
-13,500
| -81% | -$66.6K |
2020 Q1
19 quarters
|
|
13272
CALL
NLI Holdings
NL
$343M
| $16.3K | ﹤0.01% |
2,100
-2,100
| -50% | -$16.6K |
2022 Q3
9 quarters
|
|
|
BCPC
13273
PUT
Balchem Corp
BCPC
$5.29B
| $16.3K | ﹤0.01% |
100
| – | – |
2022 Q4
8 quarters
|
|
13274
PUT
Consumer Portfolio Services
CPSS
$197M
| $16.3K | ﹤0.01% |
+1,500
| New | +$15.4K |
2024 Q4
0 quarters
|
|
13275
CALL
Quest Resource Holding
QRHC
$29.5M
| $16.3K | ﹤0.01% |
2,500
-54,600
| -96% | -$401K |
2021 Q3
13 quarters
|
|
Similar funds
Citadel Advisors's Q4 2024 Portfolio in Review
As of Q4 2024, Citadel Advisors held 15,826 positions worth $578B, up 11% from $518B the previous quarter. Its ten largest holdings account for 31% of the portfolio.
Citadel Advisors's Q4 2024 filing shows 1,745 new, 6,427 increased, 6,082 reduced and 1,421 closed positions. Its largest new stake was Zoetis: 1,090,499 shares worth $178M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $1.23B.
By sector, the portfolio is most concentrated in Miscellaneous at 83% of assets, down from 83% a quarter earlier, followed by Healthcare and Technology.
- Citadel Advisors's largest Q4 2024 buy was Zoetis: 1,090,499 shares worth $178M.
- Citadel Advisors added most to Boeing in Q4 2024, an estimated $830M increase.
- Citadel Advisors's biggest Q4 2024 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $1.23B.
- Citadel Advisors fully exited Spotify in Q4 2024, selling an estimated $473M.
- Citadel Advisors's ten largest holdings make up 31% of its $578B portfolio in Q4 2024.
- Citadel Advisors opened 1,745 new positions and closed 1,421 in Q4 2024.
- Citadel Advisors's portfolio value rose 11% quarter-over-quarter to $578B.
Based on Citadel Advisors's 13F filing for Q4 2024, filed 14 Feb 2025.